Journal•ISSN: 0893-133X
Neuropsychopharmacology
Springer Science+Business Media
About: Neuropsychopharmacology is an academic journal published by Springer Science+Business Media. The journal publishes majorly in the area(s): Dopamine & Nucleus accumbens. It has an ISSN identifier of 0893-133X. Over the lifetime, 7438 publications have been published receiving 565787 citations.
Topics: Dopamine, Nucleus accumbens, Medicine, Prefrontal cortex, Agonist
Papers published on a yearly basis
Papers
More filters
TL;DR: The delineation of the neurocircuitry of the evolving stages of the addiction syndrome forms a heuristic basis for the search for the molecular, genetic, and neuropharmacological neuroadaptations that are key to vulnerability for developing and maintaining addiction.
4,160 citations
TL;DR: It is shown that human functional and structural imaging results map increasingly close to primate anatomy, and advances in neuroimaging techniques allow better spatial and temporal resolution.
3,026 citations
TL;DR: The view that addiction is the pathology that results from an allostatic mechanism using the circuits established for natural rewards provides a realistic approach to identifying the neurobiological factors that produce vulnerability to addiction and relapse.
2,678 citations
TL;DR: The investigation into DNA methylation continues to show a rich and complex picture about epigenetic gene regulation in the central nervous system and provides possible therapeutic targets for the treatment of neuropsychiatric disorders.
2,399 citations
TL;DR: Mouse genetics, allowing for selective inactivation of genes relevant for HPA regulation and molecular pharmacology, dissecting the intracellular cascade of CR signaling, are the most promising future research fields, suited for identifying genes predisposing to depression.
2,073 citations